Is SEM a good stock to buy? We came across a bullish thesis on Select Medical Holdings Corporation on Show me the incentives…’s Substack. In this article, we will summarize the bulls’ thesis on SEM. Select Medical Holdings Corporation’s share was trading at $16.41 as of April 21st. SEM’s trailing and forward P/E were 14.15 and 13.02 respectively according to Yahoo Finance.
Natallie Adams/Shutterstock.com
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. SEM is positioning itself at the center of the “Silver Tsunami” demographic trend, with founder and Executive Chairman Robert A. Ortenzio leading a take-private initiative. Ortenzio, together with his consortium, controls roughly 12.4–15% of the company and has committed financing in place from JPMorgan, Wells Fargo, and WCAS for a $16–16.20 per share buyout.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
The proposal follows the 2024 spin-off of SEM’s occupational health business, Concentra, which halved debt and generated $516 million in net proceeds, enabling a $1 billion buyback representing over half of market capitalization. SEM now focuses on its core operations across critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics, operating a combined 2,059 facilities across 39 states and D.C.
SEM’s critical illness recovery hospitals generate $2.47 billion in revenue, roughly 53% of total 2025 revenues, with 10.7% EBITDA margins and a substantial Medicare exposure of 32%. The rehabilitation hospital segment contributes $1.29 billion in revenue with 22% EBITDA margins, while the outpatient segment adds $1.28 billion with 7% margins. Collectively, these businesses produce strong free cash flow, supporting both operational growth and deleveraging initiatives.
Ortenzio’s refined take-private proposal signals urgency, with an expedited due diligence timeline and management participation in the rollover equity. Corporate governance reforms, including declassified boards and the elimination of supermajority voting, further enable the transaction.
With long-term debt at $1.85 billion and enterprise value of $3.63 billion, the deal presents a compelling risk/reward for shareholders, offering liquidity at a premium and the potential for substantial operational upside under concentrated insider ownership. SEM is thus uniquely positioned to capitalize on aging population trends while delivering near-term shareholder value through a strategic buyout.
Previously, we covered a bullish thesis on Tenet Healthcare Corporation (THC) by BlackSwanInvestor in December 2024, which highlighted Ambulatory Care growth, operational efficiency, debt reduction, and undervaluation. THC’s stock price has appreciated by approximately 52.15% since our coverage. Show me the incentives…’s thesis on Select Medical Holdings Corporation (SEM) shares a similar view but focuses on a founder-led take-private to unlock value and enhance governance.
Select Medical Holdings Corporation is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 37 hedge fund portfolios held SEM at the end of the fourth quarter which was 30 in the previous quarter. While we acknowledge the risk and potential of SEM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SEM and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
